Kenshiro Shiraishi reports 10-year findings from MRI-guided salvage radiotherapy following radical prostatectomy. In a prospective single-arm trial with 40 patients utilizing 3-Tesla multiparametric ...

Zachary Klaassen: Hi, my name is Zach Klaassen, urologic oncologist from Augusta, Georgia, and we are on UroToday at ASCO 2026 in Chicago. And I'm excited to be joined by Dr. Cornelia Ding, who is a ...

Clear Cell Renal cell carcinoma (ccRCC) is the most common form of kidney cancer. The VHL tumor suppressor is lost or mutated in the majority of ccRCC and hereditary mutations in VHL predispose ...

177Lutetium-PSMA-I&T Therapy for Metastatic Castration-Resistant Prostate Cancer (mCRPC): The First Multicenter Real-World Study of 177Lu-PSMA-I&T in Brazil - Beyond the Abstract ...

Development of a Risk Predictive Model for Erectile Dysfunction at 12 Months after COVID-19 Recovery: A Prospective Observational Study - Beyond the Abstract ...

Transdermal Application of H100 Gel to the Penile Shaft in Patients with Peyronie's Disease Infiltrates the Tunica Albuginea - Beyond the Abstract ...

Iron Biomarkers in Men with Infertility Are Associated with Sperm DNA Hydroxymethylation and Cumulative Live Birth Rates: A Prospective Study - Beyond the Abstract ...

Relationship Between the Frequency of Electrocautery of Hunner Lesions and Changes in Bladder Capacity in Patients with Hunner Type Interstitial Cystitis - Beyond the Abstract ...

Management of Asymptomatic Bacteriuria and Urinary Tract Infections in Patients with Neurogenic Bladder and Factors Associated with Inappropriate Diagnosis and Treatment - Beyond the Abstract ...

A Machine-Learning Approach to Predict Additional Treatment after Bacillus Calmette-Guérin Induction in Non-Muscle-Invasive Bladder Cancer - Beyond the Abstract ...

Geospatial Correlation of Industrial Plastics Emissions with Bladder and Kidney Cancer Burden in Ohio - Beyond the Abstract August 18, 2026 Dual loss of VHL and RASSF1A enhances tumorigenicity in ...

(UroToday.com) The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting was host to a kidney and bladder cancers poster session. Dr. Robert Motzer presented the final analysis of the ...